Soleno Therapeutics, Inc. · 12 hours ago
Summer Intern - Biostatistics
Redwood City, CA
Internship
Hybrid
Intern
$25/hr - $27/hrSoleno Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapeutics for rare diseases. They are seeking a Summer Intern in Biostatistics to gain hands-on experience in the pharmaceutical industry while assisting with various administrative and research tasks to support cross-functional projects.
BiotechnologyMedicalPharmaceutical
Responsibilities
Assist departments on various administrative projects such as organizing electronic and hard copy records and documents and assisting with literature reference searches
Assist with research and coordination for digital engagement initiatives
Support cross functional projects to improve patient and caregiver access to resources
Support research and analysis related to emerging health technologies
Support clinical trial design, setup and execution
You will contribute to a variety of projects aligned with both your interests and organizational priorities, including:
Supporting senior biostatisticians in study design, and analysis and interpretation of clinical trial data
Performing statistical analyses
Engaging cross-functionally to understand clinical context and data considerations
Contributing to internal documentation and presentations
Qualification
Required
Must be enrolled in a credited college or university at the time of the internship
Must be able to work onsite at our HQ office three days per week (Tuesday, Wednesday, and Thursday)
Possesses a can-do attitude with the ability to multi-task and take on various projects at a time
Team player with a willingness to take direction
Proficient in Microsoft Office Suite
Preferred
A degree in a science-related field is preferred but not required
Company
Soleno Therapeutics, Inc.
At Soleno Therapeutics, we believe in the power of science, advocacy, and community.
Founded in 1999
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$569.2MKey Investors
Oxford Finance LLCAbingworth
2025-07-10Post Ipo Equity· $200M
2024-12-17Post Ipo Debt· $50M
2024-05-02Post Ipo Equity· $158.7M
Leadership Team
Jim Mackaness
Chief Financial Officer
Recent News
Company data provided by crunchbase